web analytics
Drug formulations for low soluble compounds, many delivery routes | Velesco Pharma

Drug Formulation Challenge 2

Pharmaceutical Formulations are Developed for Low Solubility Compounds with Many Delivery Routes


Our client had a poorly soluble compound that they needed in a single vehicle acceptable for oral, intraperitoneal and intravenous use.


Velesco solution

  • Within one week, Velesco successfully developed a pharmaceutical formulation that met the client's target concentration, was isotonic, well tolerated by the target animal species, and was acceptable for all three routes of administration.
  • The drug formulation was simple to prepare and demonstrated a two-week stability at ambient storage.

Back to drug formulation development case studies

News and Events


In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.



New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.


Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing


1 new job postings! Careers 


Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.


Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100